Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro

Pharmacological Research

Volumn 63, Issue 5, 2011, Pages 389-397

  Marjanović, Nikola ^a   Bosnar, Martina ^a   Michielin, Francesca ^b   Willé, David R ^c   Anić Milić, Tatjana ^a   Čulić, Ognjen ^a   Popović Grle, Sanja ^d   Bogdan, Mile ^d   Parnham, Michael J ^a,e   Haber, Vesna Eraković ^a  

^a Galapagos Istraživački Centar Doo ^*  (Sri Lanka)

^b GSK   (Italy)

^c Glaxo Smith Kline   (United Kingdom)

^d University Hospital for Lung Diseases Jordanovac   (Croatia)

^e Ministarstva Zdravstva i Socijalne Skrbi RH   (Croatia)

Author keywords

Chemokines; COPD; Cytokines; Macrolide antibiotics; Sputum

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AZITHROMYCIN; CLARITHROMYCIN; CXCL1 CHEMOKINE; DEXAMETHASONE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; ERYTHROMYCIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RANTES; ROFLUMILAST; ROXITHROMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPUTUM ANALYSIS;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINES; CLARITHROMYCIN; CYTOKINES; ERYTHROMYCIN; HUMANS; MACROLIDES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROXITHROMYCIN; SPUTUM;

EID: 79955484840     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.02.001     Document Type: Article

References (48)

1. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, and P. Calverley Global initiative for chronic obstructive. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555 (Pubitemid 47403272)
2. P.J. Barnes, and B.R. Celli Systemic manifestations and comorbidities of COPD Eur Respir J 33 2009 1165 1185
3. W. MacNee Oxidants and C.O.P.D. Curr Drug Targets Inflamm Allergy 4 2005 627 641
4. K.F. Chung, and I.M. Adcock Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Eur Respir J 31 2008 1334 1356
5. S. Grumelli, D.B. Corry, L.Z. Song, L. Song, L. Green, and J. Huh An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema PLoS Med 1 2004 75 83
6. P.J. Barnes The cytokine network in chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 41 2009 631 638
7. I.K. Demedts, K.R. Bracke, G. Van Pottelberge, D. Testelmans, G.M. Verleden, and F.E. Vermassen Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 175 2007 998 1005 (Pubitemid 46741751)
8. N. Roche, and G. Huchon Reducing airways inflammation to prevent exacerbations in chronic obstructive pulmonary disease Allergy 60 2005 1350 1356 (Pubitemid 41476176)
9. M. Cazzola, S. Picciolo, and M.G. Matera Roflumilast in chronic obstructive pulmonary disease: evidence from large trials Expert Opin Pharmacother 11 2010 441 449
10. I.M. Adcock, K.F. Chung, G. Caramori, and K. Ito Kinase inhibitors and airway inflammation Eur J Pharmacol 533 2006 118 132 (Pubitemid 43340009)
11. O. Čulić, V. Eraković, and M.J. Parnham Anti-inflammatory effects of macrolide antibiotics Eur J Pharmacol 429 2001 209 229 (Pubitemid 33043997)
12. B.M. Vanaudenaerde, R. Vos, I. Meyts, S.I. De Vleeschauwer, S.E. Verleden, and A. Widyastuti-Willems Macrolide therapy targets a specific phenotype in respiratory medicine: from clinical experience to basic science and back Inflamm Allergy Drug Targets 7 2008 279 287
13. A. Azuma, and S. Kudoh Diffuse panbronchiolitis in East Asia Respirology 11 2006 249 261
14. B.M. Vanaudenaerde, I. Meyts, R. Vos, N. Geudens, W. De Wever, and E.K. Verbeken A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Eur Respir J 32 2008 832 843
15. M.H. Gotfried Macrolides for the treatment of chronic sinusitis, asthma, and COPD Chest 125 2004 52S 61S (Pubitemid 38200961)
16. M.J. Parnham, O. Čulić, V. Eraković, V. Munić, S. Popović-Grle, and K. Barišić Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment Eur J Pharmacol 517 2005 132 143 (Pubitemid 40916224)
17. J.L. Simpson, H. Powell, M.J. Boyle, R.J. Scott, and P.G. Gibson Clarithromycin targets neutrophilic airway inflammation in refractory asthma Am J Respir Crit Care Med 177 2008 148 155
18. P.A. Crosbie, and M.A. Woodhead Long-term macrolide therapy in chronic inflammatory airway diseases Eur Respir J 33 2009 171 181
19. M. Shinkai, M.O. Henke, and B.K. Rubin Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action Pharmacol Ther 117 2008 393 405
20. S. Hodge, G. Hodge, S. Brozyna, H. Jersmann, M. Holmes, and P.N. Reynolds Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages Eur Respir J 28 2006 486 495 (Pubitemid 44794662)
21. S. Hodge, G. Hodge, H. Jersmann, G. Matthews, J. Ahern, and M. Holmes Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease Am J Respir Crit Care Med 178 2008 139 148 (Pubitemid 351957772)
22. M. Bosnar, B. Bošnjak, S. Čužić, B. Hrvačić, N. Marjanović, and I. Glojnarić Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived granulocyte-macrophage colony stimulating factor and interleukin-1β J Pharm Exp Ther 331 2009 104 113
23. M.A. Dentener, R. Louis, R.H.E. Cloots, M. Henket, and E.F.M. Wouters Differences in local versus systemic TNF-α production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNF-α release Thorax 61 2006 478 484 (Pubitemid 43901516)
24. M. Profita, G. Chiappara, F. Mirabella, R. Di Giorgi, L. Chimenti, and G. Costanzo Effect of cilomilast (Ariflo) on TNF-α, IL-8, and GM-CSF release by airway cells of patients with COPD Thorax 58 2003 573 579 (Pubitemid 36808126)
25. F. Blasi, D. Bonardi, S. Aliberti, P. Tarsia, M. Confalonieri, and O. Amir Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy Pulmonol Pharmacol Ther 23 2010 200 207
26. K.M. Beeh, J. Beier, C. Lerch, A.K. Schulz, and R. Buhl Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients Lung 182 2004 369 377 (Pubitemid 40685148)
27. M. Profita, R. Gagliardo, R. Di Giorgi, A. Bruno, L. Riccobono, and A. Bonanno In vitro effects of flunisolide on MMP-9, TIMP-1, fibronectin, TGF-beta1 release and apoptosis in sputum cells freshly isolated from mild to moderate asthmatics Allergy 59 2004 927 932 (Pubitemid 39141403)
28. M. Profita, R. Gagliardo, R. Di Giorgi, F. Pompeo, M. Gjomarkaj, and G. Nicolini Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics Allergy 60 2005 323 329 (Pubitemid 40293348)
29. S. Kudoh, A. Azuma, M. Yamamoto, T. Izumi, and M. Ando Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin Am J Respir Crit Care Med 157 1998 1829 1832
30. T.A. Seemungal, T.M. Wilkinson, J.R. Hurst, W.R. Perera, R.J. Sapsford, and J.A. Wedzicha Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations Am J Respir Crit Care Med 178 2008 1139 1147
31. M. Bosnar, Kelnerić Ž, V. Munić, V. Eraković, and M.J. Parnham Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin Antimicrob Agents Chemother 49 2005 2372 2377 (Pubitemid 40734469)
32. V. Stepanić, S. Koštrun, I. Malnar, M. Hlevnjak, K. Butković, and I. Ćaleta Modeling cellular pharmacokinetics of 14- and 15-membered macrolides with physicochemical properties J Med Chem 2011 10.1021/jm101317f
33. P. Kurath, P.H. Jones, R.S. Egan, and T.J. Perun Acid degradation of erythromycin A and erythromycin B Experientia 27 1971 362
34. D. Banerjee, D. Honeybourne, and O.A. Khair The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial Treat Respir Med 3 2004 59 65 (Pubitemid 38444332)
35. I. Basyigit, F. Yildiz, S.K. Ozkara, E. Yildirim, H. Boyaci, and A. Ilgazli The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data Ann Pharmacother 38 2004 1400 1405 (Pubitemid 39100191)
36. O. Čulić, V. Eraković, I. Čepelak, K. Barišić, K. Brajša, and Ferenčić Ž Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects Eur J Pharmacol 450 2002 277 289
37. M. Shinkai, G.H. Foster, and B.K. Rubin Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol 290 2006 L75 85
38. M.J. Schultz, P. Speelman, C.E. Hack, W.A. Buurman, S.J. van Deventer, and T. van Der Poll Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae J Antimicrob Chemother 46 2000 235 240 (Pubitemid 30642517)
39. C. Costa, R. Rufino, S.L. Traves, E. Lapa, J.R. Silva, and P.J. Barnes CXCR3 and CCR5 chemokines in induced sputum from patients with COPD Chest 133 2008 26 33
40. C.M. Freeman, J.L. Curtis, and S.W. Chensue CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity Am J Pathol 171 2007 767 776 (Pubitemid 47440976)
41. S. Ying, B. O'Connor, J. Ratoff, Q. Meng, C. Fang, and D. Cousins Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease J Immunol 181 2008 2790 2798
42. T.L. Hackett, R. Holloway, S.T. Holgate, and J.A. Warne Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study Respir Res 9 2008 47
43. A.A. Khan, T.R. Slifer, F.G. Araujo, and J.S. Remington Effect of clarithromycin and azithromycin on production of cytokines by human monocytes Int J Antimicrob Agents 11 1999 121 132 (Pubitemid 29114971)
44. L.M. Kent, L.J. Smyth, J. Plumb, C.L. Clayton, S.M. Fox, D.W. Ray, and S.N. Farrow Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6- difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504) J Pharmacol Exp Ther 328 2009 458 468
45. S.V. Culpitt, D.F. Rogers, P. Shah, C. De Matos, R.E.K. Russell, and L.E. Donnelly Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 2003 24 31 (Pubitemid 36015913)
46. M.R. Edwards, M.W. Johnson, and S.L. Johnston Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells Am J Respir Cell Mol Biol 34 2006 616 624
47. X. Xu, H. Wang, Z. Wang, and W. Xiao Plasminogen activator inhibitor-1 promotes inflammatory process induced by cigarette smoke extraction or lipopolysaccharides in alveolar epithelial cells Exp Lung Res 35 2009 795 805
48. Y.J. Park, G. Liu, E.F. Lorne, X. Zhao, J. Wang, and Y. Tsuruta PAI-1 inhibits neutrophil efferocytosis Proc Natl Acad Sci U S A 105 2008 11784 11789